Gabriëla Wright

1.3k citations

20 papers · 1.1k indexed · h-index 15

Impact in

Oncology top 10%
- Cytokine Signaling Pathways and Interactions
- Cancer-related Molecular Pathways
Cancer Research top 10%
- MicroRNA in disease regulation

Papers in ⓘ

Oncology 8
- Cancer-related Molecular Pathways 4
Immunology 5
- T-cell and B-cell Immunology 3
- Immune Cell Function and Interaction 3
- Immunotherapy and Immune Responses 3

Co-authors: Kenneth L. Wright (6 shared papers)W. Douglas Cress (6 shared papers)Yihong Ma (2 shared papers)Jiangdong Chen (1 shared paper)James G. Karras (1 shared paper)Guilian Niu (1 shared paper)Mei Huang (1 shared paper)Hua Yu (1 shared paper)
Journals: Journal of Biological Chemistry (4 papers)PLoS ONE (2 papers)Cancer Research (2 papers)ACS Chemical Biology (2 papers)Molecular Cancer Therapeutics (1 paper)
Partner nations: United States Puerto Rico China

In The Last Decade

Gabriëla Wright

20 papers receiving 1.1k citations

Peers

Countries citing papers authored by Gabriëla Wright

Since Specialization

Citations

This map shows the geographic impact of Gabriëla Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriëla Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriëla Wright more than expected).

Fields of papers citing papers by Gabriëla Wright

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriëla Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriëla Wright. The network helps show where Gabriëla Wright may publish in the future.

Co-authors

The 25 scholars most cited alongside Gabriëla Wright, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gabriëla Wright Line = papers co-authored together Gabriëla Wright links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Role of Stat3 in Regulating p53 Expression and Function Molecular and Cellular Biology ·Guilian Niu, Kenneth L. Wright, Yihong Ma, Gabriëla Wright, Mei Huang, Rosalyn Irby, Jon Briggs, James G. Karras, W. Douglas Cress, Drew M. Pardoll, Richard Jove, Jiangdong Chen, Hua Yu	2005	332
2	Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas Oncogene ·X Zhang, X Chen, Jianhong Lin, Tint Lwin, Gabriëla Wright, Lynn C. Moscinski, William S. Dalton, Edward Seto, Kristal Wright, Eduardo M. Sotomayor, Jianguo Tao	2011	137
3	Proteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets Cell chemical biology ·Claire E. Knezevic, Gabriëla Wright, Lily L. Remsing Rix, Woosuk Kim, Brent M. Kuenzi, Yunting Luo, January M. Watters, John M. Koomen, Eric B. Haura, Álvaro N.A. Monteiro, Caius G. Radu, Harshani R. Lawrence, Uwe Rix	2016	77
4	GSK3 Alpha and Beta Are New Functionally Relevant Targets of Tivantinib in Lung Cancer Cells ACS Chemical Biology ·Lily L. Remsing Rix, Brent M. Kuenzi, Yunting Luo, Elizabeth Remily-Wood, Fumi Kinose, Gabriëla Wright, Jiannong Li, John M. Koomen, Eric B. Haura, Harshani R. Lawrence, Uwe Rix	2013	74
5	Tipifarnib and Bortezomib Are Synergistic and Overcome Cell Adhesion–Mediated Drug Resistance in Multiple Myeloma and Acute Myeloid Leukemia Clinical Cancer Research ·Niranjan Yanamandra, Nandita M. Colaco, Nancy Parquet, Robert Buzzeo, David Boulware, Gabriëla Wright, Lia Perez, William S. Dalton, Darrin M. Beaupre	2006	73
6	Positive Regulatory Domain I Binding Factor 1 Silences Class II Transactivator Expression in Multiple Myeloma Cells Journal of Biological Chemistry ·Nilanjan Ghosh, Ildikó Győry, Gabriëla Wright, Justin Wood, Kenneth L. Wright	2001	59
7	Dual Targeting of WEE1 and PLK1 by AZD1775 Elicits Single Agent Cellular Anticancer Activity ACS Chemical Biology ·Gabriëla Wright, Volha A. Golubeva, Lily L. Remsing Rix, Norbert Berndt, Yunting Luo, Grace Ward, Jhanelle E. Gray, E. Schönbrunn, Harshani R. Lawrence, Álvaro N.A. Monteiro, Uwe Rix	2017	57
8	A Novel Element and a TEF-2-like Element Activate the Major Histocompatibility Complex Class II Transactivator in B-lymphocytes Journal of Biological Chemistry ·Nilanjan Ghosh, Janet F. Piskurich, Gabriëla Wright, Kevin Hassani, Jenny P.‐Y. Ting, Kenneth L. Wright	1999	50
9	Positive Regulatory Domain I (PRDM1) and IRF8/PU.1 Counter-regulate MHC Class II Transactivator (CIITA) Expression during Dendritic Cell Maturation Journal of Biological Chemistry ·Matthew A. Smith, Gabriëla Wright, Jian Wu, Prafullakumar Tailor, Keiko Ozato, Xianghong Chen, Sheng Wei, Janet F. Piskurich, Jenny P.‐Y. Ting, Kenneth L. Wright	2011	48
10	Critical Role of the Tumor Suppressor Tuberous Sclerosis Complex 1 in Dendritic Cell Activation of CD4 T Cells by Promoting MHC Class II Expression via IRF4 and CIITA The Journal of Immunology ·Hongjie Pan, Thomas O’Brien, Gabriëla Wright, Jialong Yang, Jinwook Shin, Kenneth L. Wright, Xiao‐Ping Zhong	2013	45
11	A Role for the Retinoblastoma Protein As a Regulator of Mouse Osteoblast Cell Adhesion: Implications for Osteogenesis and Osteosarcoma Formation PLoS ONE ·Bernadette Sosa-García, Volkan Gündüz, Viviana Vázquez‐Rivera, W. Douglas Cress, Gabriëla Wright, Haikuo Bian, Philip W. Hinds, Pedro G. Santiago‐Cardona	2010	29
12	Randomized phase II trial of nanoparticle albumin-bound paclitaxel in three dosing schedules with bevacizumab as first-line therapy for HER2-negative metastatic breast cancer (MBC) Journal of Clinical Oncology ·Alison Conlin, C. Hudis, A M Bach, Mary Ellen Moynahan, Diana Lake, A. Forero-Torres, Gabriëla Wright, Mary Helen Hackney, Alicia Clawson, A. D. Seidman	2009	23
13	PAXIP1 Potentiates the Combination of WEE1 Inhibitor AZD1775 and Platinum Agents in Lung Cancer Molecular Cancer Therapeutics ·Ankita Jhuraney, Nicholas T. Woods, Gabriëla Wright, Lily L. Remsing Rix, Fumi Kinose, Jodi L. Kroeger, Elizabeth Remily-Wood, W. Douglas Cress, John M. Koomen, Stephen G. Brantley, Jhanelle E. Gray, Eric B. Haura, Uwe Rix, Álvaro N.A. Monteiro	2016	21
14	CDKN1C Negatively Regulates RNA Polymerase II C-terminal Domain Phosphorylation in an E2F1-dependent Manner Journal of Biological Chemistry ·Yihong Ma, Lü Chen, Gabriëla Wright, Smitha Pillai, Srikumar Chellappan, W. Douglas Cress	2010	20
15	Histone deacetylase 8 inhibition suppresses mantle cell lymphoma viability while preserving natural killer cell function Biochemical and Biophysical Research Communications ·January M. Watters, Gabriëla Wright, Matthew A. Smith, Bijal Shah, Kenneth L. Wright	2020	19
16	Familial XX chromosomal maleness does not arise from a Y chromosomal translocation The Journal of Pediatrics ·Harry Ostrer, Gabriëla Wright, Mark Clayton, Nicos Skordis, Margaret H. MacGillivray	1989	10
17	CDK4/6 inhibition synergizes with inhibition of P21-Activated Kinases (PAKs) in lung cancer cell lines PLoS ONE ·Gabriëla Wright, Nick T. Gimbrone, Bhaswati Sarcar, Trent R. Percy, Edna R. Gordián, Fumi Kinose, Natália J. Sumi, Uwe Rix, W. Douglas Cress	2021	4
18	Characterization of epidermal growth factor receptor (EGFR) P848L, an unusual EGFR variant present in lung cancer patients, in a murine Ba/F3 model FEBS Open Bio ·Bhaswati Sarcar, Nicholas T. Gimbrone, Gabriëla Wright, Lily L. Remsing Rix, Edna R. Gordián, Uwe Rix, Alberto Chiappori, Gary W. Reuther, Pedro G. Santiago‐Cardona, Teresita Muñoz‐Antonia, W. Douglas Cress	2019	4
19	Abstract 675: Off-target based drug repurposing opportunities for tivantinib in acute myeloid leukemia Cancer Research ·Brent M. Kuenzi, Lily L. Remsing Rix, Sateesh Kunigal, Fumi Kinose, Claire E. Knezevic, Gabriëla Wright, Jodi L. Kroeger, Jeffrey E. Lancet, Eric Padron, Uwe Rix	2015	1
20	P1-14-01: Randomized Phase II Trial of Weekly vs. q 2-Weekly vs. q 3-Weekly Nanoparticle Albumin-Bound Paclitaxel with Bevacizumab as First-Line Therapy for Metastatic Breast Cancer. Cancer Research ·A. D. Seidman, AK Conlin, A M Bach, Andres Forero‐Torres, Gabriëla Wright, MH Hackney, Alicia Clawson, D. Schofield, J.L. Fernández Iglesias, CA Hudis	2011	1

About Gabriëla Wright

Gabriëla Wright is a scholar working on Oncology, Immunology, Hematology, Pathology and Forensic Medicine and Immunology and Allergy, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), Protein Degradation and Inhibitors (3 papers), T-cell and B-cell Immunology (3 papers), Immune Cell Function and Interaction (3 papers), Immunotherapy and Immune Responses (3 papers), Advanced Breast Cancer Therapies (3 papers), Cancer Mechanisms and Therapy (3 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Oncology (450 citations), Cancer Research (195 citations), Immunology (268 citations), Molecular Biology (636 citations) and Hematology (82 citations). Gabriëla Wright has collaborated with scholars based in United States, Puerto Rico and China. Frequent co-authors include Kenneth L. Wright, W. Douglas Cress, Yihong Ma, Jiangdong Chen, James G. Karras, Guilian Niu, Mei Huang, Hua Yu, Rosalyn Irby and Richard Jove. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE, Cancer Research, ACS Chemical Biology and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact